| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |